Beiersdorf divests Bode
This article was originally published in The Rose Sheet
Executive Summary
German personal-care firm Beiersdorf has sold its affiliate Bode Chemie to Paul Hartmann AG for an undisclosed sum, firm says Oct. 20. Bode Chemie, one of "Europe's leading specialists for disinfection, hygiene and skin protection," generated about $93.3 mil. in sales in 2007, Beiersdorf says. Divestiture is in line with firm's strategy to focus on its skin- and beauty-care offerings and "increas[e] its orientation on the growing cosmetics market." Beiersdorf's Thomas-B. Quaas, chairman of the executive board, states: "Beiersdorf can create good prospects for its affiliate by selling it to Hartmann while systematically pursuing its own successful course in the international growth markets for skin and beauty care." Bode Chemie pickup will allow Hartmann to expand its hygiene products range into the infection prevention market
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.